All News
Dr. Philip Mease on the importance of recognizing fibromyalgia, especially concurrently with rheumatic diseases
FM does impact disease severity, esp in RA and AS
@RheumNow #RNL2022 https://t.co/cGFYYdf6GU
Robert B Chao, MD doctorRBC ( View Tweet)
Dr. Jonathan Hausman on JIA
Most subjects equivalent to adult forms of inflammatory arthritis - note early onset seronegative oligoarthritis
Tips on transitioning to adult care - determine extent of active disease vs. chronic damage
@RheumNow #RNL2022 https://t.co/MhjH04PQ3e
Robert B Chao, MD doctorRBC ( View Tweet)
Transition programs improve health and QoL of pedi-to-adult rheumatology patients in addition to their autonomy/independence! Dr. @hausmannMD gives both pediatric and adult recommendations to ease care at #RNL2022 @RheumNow https://t.co/e5erQ5nkcE
Dr. Rachel Tate uptoTate ( View Tweet)
Wow.. #JIA patients evolve into different categories over time. Dr Jon Hausmanns talk at #RNL2022 @hausmannMD https://t.co/fefXB2fFmJ
Dr. John Cush RheumNow ( View Tweet)
If you don’t treat active #rheumatoidarthritis while woman 👩 is pregnant, you may do more harm to 👶🏻. Look at the data @UmaMahadevanIBD #RNL2022 @RheumNow https://t.co/6P94IdfS15
Janet Pope Janetbirdope ( View Tweet)
Seropositivity Linked to Bronchiectasis in Rheumatoid Arthritis
Rheumatoid arthritis associated bronchiectasis (RA-BR) is uncommon, and is unrelated to interstitial lung disease (ILD), but like ILD, can substantially impact RA outcomes.
Read Article
Environmental Pollutants Ups Autoimmune Disease Risk
An Italian environmental study shows that air pollution increases the risk of autoimmune diseases, in particular rheumatoid arthritis, connective tissue diseases (CTDs) and inflammatory bowel diseases (IBD).
Read Article
Low Dose IL-2 Efficacy in Rheumatoid Arthritis
A novel biologic intervention trial has shown that subcutaneous, intermittent therapy with low-dose interleukin-2 (Ld-IL2) is potentially effective and safe in rheumatoid arthritis (RA).
Read Article
Korean study (TB endemic area) shows the risk of mTB & nontuberculous mycobact infx (NTM) are equal and nearly doubled in RA pts on TNFi. Among 4356 RA (1089 on TNFi) NTM & TB rates were 328- and 341/100K PY (US rate is 6/100K PY) https://t.co/QwzTYt3wX4 https://t.co/GLWreoQ6ih
Dr. John Cush RheumNow ( View Tweet)
RheumNow Live is Coming to Town!
Have you signed up for RheumNow Live yet? We still have space available.
https://t.co/FBCQRu32gO
https://t.co/KoGR8An6af https://t.co/qtwPbMzqSO
Links:
Dr. John Cush RheumNow ( View Tweet)
RheumNow Live is Coming to Town!
Have you signed up for RheumNow Live yet? We still have space available.
https://t.co/FBCQRu32gO
https://t.co/KoGR8An6af https://t.co/qtwPbMzqSO
Links:
Dr. John Cush RheumNow ( View Tweet)
ICYMI: Undifferentiated Arthritis Does Not Follow an RA Course
UA is common in medical practice and many advocate early use of DMARDs; yet a recent study shows that despite DMARD use, UA patients do not fair well with this approach.
https://t.co/l0U4IVAXMG https://t.co/8YPM8DgX8H
Links:
Dr. John Cush RheumNow ( View Tweet)
6780 nonspecific MSK pts (no synovitis) saw 3% w/ CCP+, 45% progressed to IA (RA). Progression seen w/ high CCP (OR 9.4), hand (OR 2.7) & foot pain (OR 4.1). CCP- progress if pain in hands (OR 2.5) or knees. 96% NPV for CCP- w/o hand/foot pain https://t.co/FbDIggQFLJ https://t.co/VtvRUOHTnc
Links:
Dr. John Cush RheumNow ( View Tweet)
Undifferentiated Arthritis Does Not Follow an RA Course
Undifferentiated arthritis (UA) is common in medical practice and many advocate early use of DMARDs; yet a recent study shows that despite DMARD use, UA patients do not fair well with this approach.
Read Article
Drug Survival Differences in RA, PsA, SpA and PsO
https://t.co/aBRhTbVmCM https://t.co/ZDGiKlowoV
Links:
Dr. John Cush RheumNow ( View Tweet)
Rheumatoid Arthritis and Eosinophilia
Considerations when eosinophilia is seen in RA patients.
QD Clinic is sponsored by https://t.co/4UQlqwujiR (March 19 & 20, 2022 in Las Colinas, Texas)
https://t.co/2FszCiTLgf https://t.co/07uZT2heW3
Links:
Dr. John Cush RheumNow ( View Tweet)
Rheumatoid Arthritis and Eosinophilia
Considerations when eosinophilia is seen in RA patients.
QD Clinic is sponsored by https://t.co/4UQlqwujiR (March 19 & 20, 2022 in Las Colinas, Texas)
https://t.co/2FszCiTLgf https://t.co/07uZT2heW3
Links:
Dr. John Cush RheumNow ( View Tweet)
New Download Available!
Autoimmune Disease in the USA
https://t.co/KvsgBUY7mL https://t.co/PSTF7ma6G6
Links:
Dr. John Cush RheumNow ( View Tweet)
Download this week’s podcast titled “When Less (Drug) is More (Activity) “
https://t.co/FESVNenri9 https://t.co/PVGGjkgcTV
Links:
Dr. John Cush RheumNow ( View Tweet)
French GAZEL study of 20,625 pts showed a confirmed RA Dx was significantly assoc w/ increased CV risk (HR 3.03; 1.13–8.11) independent of usual CV risk factors. RF or ACPA (+) without RA was not associated with CV events https://t.co/DG8o5d9hHE https://t.co/5n9uDAhSrF
Links:
Dr. John Cush RheumNow ( View Tweet)